dimigal 50 mg/1 tableta tableta
galenika d.o.o. - dimenhidrinat - tableta - 50 mg/1 tableta - 1 tableta sadrži: 50 mg dimenhidrinata
histinax 24 mg/1 tableta tableta
bosnalijek d.d. - betahistin - tableta - 24 mg/1 tableta - 1 tableta sadrži: 24 mg betahistin dihidrohlorida
histinax 24 mg/1 tableta tableta
bosnalijek d.d. - betahistin - tableta - 24 mg/1 tableta - 1 tableta sadrži: 24 mg betahistin dihidrohlorida
gentamicin b. braun 3 mg/ml otopina za infuziju
b. braun adria d.o.o., hondlova 2/9, zagreb - gentamicinsulfat - otopina za infuziju - 3 mg/ml - urbroj: 1 ml otopine za infuziju sadrži 3 mg gentamicina u obliku gentamicin sulfata
tremfya
janssen-cilag international nv - guselkumab - psorijaza - imunosupresivi - plaque psoriasis tremfya is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritis tremfya, alone or in combination with methotrexate (mtx), is indicated for the treatment of active psoriatic arthritis in adult patients who have had an inadequate response or who have been intolerant to a prior disease-modifying antirheumatic drug (dmard) therapy (see section 5.
skyrizi
abbvie deutschland gmbh & co. kg - risankizumab - psoriasis; arthritis, psoriatic - imunosupresivi - plaque psoriasisskyrizi is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisskyrizi, alone or in combination with methotrexate (mtx), is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). crohn's diseaseskyrizi is indicated for the treatment of adult patients with moderately to severely active crohn's disease who have had an inadequate response to, lost response to, or were intolerant to conventional therapy or a biologic therapy.
padcev
astellas pharma europe b.v. - enfortumab vedotin - carcinoma, transitional cell; urologic neoplasms - antineoplastična sredstva - padcev as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic urothelial cancer who have previously received a platinum-containing chemotherapy and a programmed death receptor 1 or programmed death ligand 1 inhibitor.
filsuvez
amryt pharmaceuticals dac - dry extract from birch bark (der 5-10 : 1), extraction solvent n-heptane 95% (w/w) - epidermolysis bullosa dystrophica; epidermolysis bullosa, junctional - pripravci za liječenje rana i ulkusa - treatment of partial thickness wounds associated with dystrophic and junctional epidermolysis bullosa (eb) in patients 6 months and older.
circovac
ceva-phylaxia oltóanyagtermelõ zrt. - inaktivirani svinjski cirkovirus tipa 2 (pcv2) - imunološke za suidae - svinje (nazimice i krmače) - giltspassive imunizacije krmača i prasadi kroz kolostrum, nakon aktivne imunizacije krmača i popravak svinje, za smanjenje lezija u лимфоидных tkivima, u svezi s ЦВС2 infekcije i kao pomoćno sredstvo za smanjenje ЦВС2 vezane uz smrtnosti. pigletsactive imunizacija prasadi za smanjenje fekalne izlučivanje ЦВС2 i količine virusa u krvi, a kao pomoć za smanjenje ЦВС2 koji su vezani za kliničke znakove, uključujući i iscrpljenost, gubitak težine i smrtnosti, kao i za smanjenje količine virusa i poraza u лимфоидных tkiva, povezanih s infekcijom pcv2 u.
meloxoral
dechra regulatory b.v. - mcloksikam - musculo-skeletal system, anti-inflammatory and anti-rheumatic products, non-steroids - dogs; cats - catsalleviation upale i bolove u lumbalnom poremećaji mišićno-koštanog sustava. dogsalleviation upale i bolova u akutni i kronični mišićno-koštanog sustava.